PMHNP Practice Authority in Arizona: Independence, Physician Agreements and Schedule II

AANP's May 2026 map puts Arizona in its full practice tier.

The label is AANP's advocacy classification; the legal fact behind it sits in the licence definition itself.

A.R.S. § 32-1601(23) defines the practice of a registered nurse practitioner to include making independent decisions and diagnosing and prescribing legend drugs, medical devices and controlled substances, on meeting the requirements established by the board.

No collaboration requirement appears in the definition.

What the board requires for controlled-substance prescribing is in A.A.C.

R4-19-511, covered below.

Arizona sets no hours or years threshold that a new graduate must serve before practising to the licence's full scope.

Neither § 32-1601 nor R4-19-511 contains one.

The only numeric gate in the sources read is educational, not experiential: the 45 contact hours are one of the R4-19-511(A) conditions for prescribing and dispensing authority.

A graduate counts classroom contact hours, not supervised practice months, and a PMHNP moving in from a state with a transition period finds no equivalent supervised phase here.

No collaborative or supervisory agreement with a physician is required at any career stage.

The statute's guardrail is a professional-judgment duty instead: the RNP must recognize the limits of the RNP's own knowledge and experience by consulting with or referring patients to other appropriate health care professionals when a situation or condition is beyond that knowledge and experience, or when the referral would protect the patient's health and welfare.

That is a duty on the clinician, not a structural control through a physician's signature.

The board grants prescribing and dispensing authority only if the applicant meets R4-19-511(A)'s conditions, including submitting evidence of a minimum of 45 contact hours of education within the three years immediately preceding the application, covering pharmacology or clinical management of drug therapy.

Once granted, that authority covers controlled substances within the RNP's population focus.

So an outpatient Arizona PMHNP can prescribe Schedule II ADHD stimulants: the only Schedule II restriction in the rule is on dispensing, not prescribing.

General opioid limits in other A.R.S. sections were not read, and no separate state controlled-substance registration was found in the sources read.

R4-19-511(D) carries the constraints that come with the authority: no prescribing a controlled substance to oneself, a family member, or any other person whose relationship with the RNP could affect the RNP's independent, objective and sound judgment; no prescribing outside the RNP's population focus; no prescribing without having examined the person and established a professional relationship, with limited exceptions; and no prescribing in a manner inconsistent with other state or federal requirements — the rule's own link to the general opioid statutes outside the sources read.

Federally, a PMHNP registers with the DEA as a mid-level practitioner, and that registration covers only what Arizona lets the RNP prescribe.

The DEA and HHS telemedicine flexibilities, extended through December 31, 2026, remove the federal in-person visit requirement for remote prescribing; they do not change any Arizona rule.

HB 2310, introduced in the 2025 regular session by Representative Bliss, would add A.R.S. title 32, chapter 15, article 2.2 adopting the APRN Compact.

Only the introduced version was found on the legislature's site; the engrossed and chaptered texts return 404, so the bill was not enacted as far as located.

Bill number HB 2310 in the 2026 session is an unrelated bill about qualified marketplace contractors.

Nationwide, the compact takes effect only once seven states enact it and five had as of September 2026, so no APRN holds a multistate APRN licence today; the Nurse Licensure Compact is an RN compact and gives no nurse practitioner authority.

To practise as a PMHNP in Arizona you need Arizona RNP recognition and Arizona prescribing and dispensing authority.

No change to Arizona's RNP practice or prescribing rules across 2023 through 2026 was found in the sources read.

The prescribing rule itself predates that window: per its history note, R4-19-511 was first adopted effective November 25, 1996, the current section was made by final rulemaking effective November 12, 2005, and it was last amended by final rulemaking at 26 A.A.R.

3289, effective December 2, 2020.

The compact bill was the only recent legislative activity the sources showed, and it was not enacted as far as located.